Tue.Jul 16, 2024

article thumbnail

At an Iowa county fair, a tradition carries on despite bird flu anxiety in the dairy barn

STAT

DECORAH, Iowa — It was livestock check-in day at the Winneshiek County Fair, and the dairy barn was consumed with a kind of pre-prom anxiety. A cow named Daiquiri was lumbering back from the milking parlor, adjusting to a new schedule that would have her “mammary system” bulging for showtime. Kennedy was getting a fresh shave, tufts of udder-fuzz drifting to the floor, revealing her resplendent venation.

363
363
article thumbnail

Has pharma emerged from the ‘age of uncertainty’?

PharmaVoice

An industry reeling from a precarious market is showing signs of stabilizing as the future becomes a little less cloudy, an Evaluate report suggests.

264
264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

USDA maintains bird flu can be eliminated from dairy cows, even as doubts mount among experts

STAT

Facing increasing doubts that the U.S. can control the outbreak of avian influenza among dairy cattle, federal officials reiterated on Tuesday that they believe the country can still eliminate the H5N1 virus from dairy cows, even as it continues to spread to new herds. “All the signs that we have are, with good biosecurity, with good farmer participation, we will be able to eliminate this,” Eric Deeble, the acting senior adviser for the H5N1 response at the U.S.

363
363
article thumbnail

FDA’s lab developed test rule could be first check on agency’s power post-Chevron

PharmaVoice

The Supreme Court’s decision to overturn the Chevron doctrine would make it easier to challenge agency regulations, such as the LDT final rule.

147
147
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Long Covid is more prevalent among Americans with disabilities, new CDC data show

STAT

The Centers for Disease Control and Prevention just released a trove of data on Americans with disabilities that found that more than a quarter of U.S. adults have a disability — over 70 million people, a bump from prior years. This slice of the population was also much more likely to report long Covid symptoms such as chronic fatigue and brain fog.

363
363
article thumbnail

Study finds Parkinson’s disease SLT more effective than one used in NHS

Pharma Times

The progressive neurodegenerative condition affects around 153,000 people in the UK

135
135

More Trending

article thumbnail

South-east London pharmacies launch inhaler recycling pilot

The Pharmacist

Community pharmacies in south-east London have launched what is believed to be England’s only nationally-funded inhaler recycling pilot. NHS England (NHSE) has funded the scheme, which aims to reduce greenhouse gases from metered dose inhalers. Patients will be encouraged to return their used or expired inhalers to one of 20 participating community pharmacies.

article thumbnail

STAT+: Applesauce lead contamination could not have been prevented, top FDA officials says

STAT

CHICAGO – The FDA’s top food regulator contended Tuesday that the agency could not have done much more to prevent the recent contamination of children’s applesauce with lead. The official, Food and Drug Administration Deputy Commissioner Jim Jones, argued that if companies like the producer of the lead-laced cinnamon in the applesauce “are hell bent about breaking the rules, they’re usually going to get away with it for a little while before they’re stop

343
343
article thumbnail

Sionna revives AbbVie’s cystic fibrosis drugs, eyeing a shot at Vertex

BioPharma Dive

The well-funded startup says drugs AbbVie abandoned last year could form a combination regimen with “superior efficacy” to Vertex’s market-leading medicines.

116
116
article thumbnail

STAT+: A cancer care startup is making a new bet with payers and providers: only pay if it works

STAT

A cancer care navigation startup has raised $95 million from prominent tech investors to help payers and providers spend less on cancer patients while improving their health — including by doling out incentive payments to providers and keeping a cut of insurers’ savings. Thyme Care’s Series C round included new investor Concord Health Partners, and repeat investors such as Town Hall Ventures, Andreessen Horowitz, Foresite Capital and CVS Health Ventures, the company tol

338
338
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

KCL leads first guidelines on immune monitoring for hard-to-treat blood cancer

Pharma Times

Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK

Immunity 113
article thumbnail

Opinion: Addressing the dual epidemics of hepatitis C and opioid use

STAT

Hepatitis C and opioid use disorder are both chronic but treatable conditions. Yet many Americans living with this deadly combination aren’t offered treatment. Imagine going to your doctor with strep throat and instead of being prescribed an antibiotic you are told it isn’t urgent and you can wait to treat it. A solution is within reach: It starts with recognizing the power of integrating hepatitis C treatment with addiction care.

331
331
article thumbnail

Novo leads $100m financing for Alzheimer's player Asceneuron

pharmaphorum

Novo Holdings leads $100m financing for Swiss biotech Asceneuron, which is developing an oral tau therapy for Alzheimer's disease

111
111
article thumbnail

STAT+: Cardiovascular startup raises $260 million led by ex-Moderna execs’ new VC fund

STAT

Cardurion Pharmaceuticals, a startup that launched seven years ago with shelved cardiovascular drug candidates from Takeda Pharmaceuticals, has raised $260 million for a Series B round.  The financing was led by Ascenta Capital, a new VC firm that has quietly begun leading biotech investment deals while raising its first fund. Ascenta was started last year by Moderna’s former finance chief Lorence Kim and former head of strategy Evan Rachlin.

article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

NHS on course to use digital tech to diagnose ADHD

pharmaphorum

A digital diagnostic for ADHD called QbTest should be used by the NHS as an add-on to standard assessment, says new NICE guidance

111
111
article thumbnail

STAT+: UnitedHealth CEO concedes company was ‘over-optimistic’ about Change cyberattack recovery

STAT

UnitedHealth Group’s CEO said Tuesday that his team was “over-optimistic” about the pace at which providers would reconnect with Change Healthcare after the claims-processing unit sustained a sweeping cyberattack. Andrew Witty’s comments came toward the end of the company’s second-quarter earnings call, in which UnitedHealth disclosed it now expects to shoulder an up to $1.9 billion post-tax hit from the mid-February cyberattack, higher than the $1.6 billion es

313
313
article thumbnail

Lupin receives tentative approval from U.S. FDA for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride tablets

Express Pharma

Lupin today announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Sodium Sulfate, Magnesium Sulfate, and Potassium Chloride Tablets, 1.479 g/0.225 g/0.188 g , to market a generic equivalent of Sutab Tablets, 1.479 g/0.225 g/0.188 g, of Braintree Laboratories. “Lupin is the exclusive first-to-file for this product and may be eligible for 180-day exclusivity.

110
110
article thumbnail

Addressing the “postpartum cliff” may be as simple as a sending few text messages

STAT

Most pregnant people are in regular touch with their maternity care providers over the course of nine months, with ever-more-frequent visits, tests, and scans as their due date nears. For many patients, this is the first time in their lives they’ve been in such close, routine contact with the health system. Then, after delivering the child, this attention all but vanishes.

Diabetes 284
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

GLP-1 bonanza spurs big investment at CDMO CordenPharma

pharmaphorum

CordenPharma has launched a €900 million ($981 million) investment programme to prepare for an expected surge in demand for peptide production capacity – driven by GLP-1 receptor agonists.The three-year plan revolves around parallel programmes in the US and Europe that will include new builds and upgrades and expansion to its existing facilities, according to the German contract development and manufacturing organisation (CDMO).

109
109
article thumbnail

STAT+: Pharmalittle: We’re reading about Vertex suing HHS over a fertility program, Hawaii losing a PBM suit, and more

STAT

Top of the morning to you. Another steamy day is unfolding here at the Pharmalot campus, where the official mascots are scampering about and enjoying summertime fun.  As for the rest of us, well, we can only dream. But our to-do list will keep us busy, including chats with some interesting folks. Hopefully, you can relate. Either way, it is time to get cracking.

277
277
article thumbnail

Artiva announces terms for its second IPO attempt

pharmaphorum

Natural killer cell therapy specialist Artiva Biotherapeutics has another go at an IPO, hoping to raise up to $135m

108
108
article thumbnail

Roche looks to have a competitive GLP-1 drug

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. The weather here in Chicago has been super volatile. We’ve had thunderstorms the last few days, and last night I heard for the first time a  tornado warning. Truly an ominous start to the week!

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Navigating Patent Opposition in Drug Patenting: A Comprehensive Guide

Drug Patent Watch

Introduction Patent oppositions are a crucial tool in the pharmaceutical industry, allowing civil society to challenge the validity of patents […] Source

105
105
article thumbnail

6 Ways You Can Practice Unreasonable Hospitality in Your Pharmacy

PioneerRx

If you’re a long-time reader of our blogs, you might be familiar with the phrase “ is the name of the game,” and rightfully so. The pharmacy industry consists.

Hospitals 105
article thumbnail

AstraZeneca completes Amolyt Pharma acquisition

Pharmaceutical Technology

AstraZeneca has closed the acquisition of Amolyt Pharma, a company specialising in treatments for rare endocrine diseases.

103
103
article thumbnail

Glenmark Pharmaceuticals receives ANDA approval for Topiramate Capsules USP, 15 mg and 25 mg

Express Pharma

Glenmark Pharmaceuticals has received final approval by the United States Food & Drug Administration (U.S. FDA) for Topiramate Capsules USP, 15 mg and 25 mg. Glenmark’s Topiramate Capsules USP, 15 mg and 25 mg has been determined by the FDA to be bioequivalent and therapeutically equivalent ( 1) to Topamax ( 2) Capsules, 15 mg and 25 mg of Janssen Pharmaceuticals, and will be distributed in the U.S. by Glenmark Pharmaceuticals, USA.

Labelling 100
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Analysis Finds Misinformation About Interchangeable Biosimilars Undermining US Health Policy, Physician Confidence, and Patient Health

Safe Biologics

WASHINGTON, July 16, 2024 – The Alliance for Safe Biologic Medicines (ASBM) announces the publication of a paper underscoring the critical role of the FDA’s interchangeable biosimilar data requirements in maintaining the safety and efficacy of biosimilar substitutions. Titled “Misinformation about interchangeable biosimilars undermines US health policy, physician confidence, and patient health,” the paper discusses the successes of the FDA’s data-driven approach in building physicia

article thumbnail

Pfizer advances development of once-daily formulation of oral GLP-1 receptor agonist danuglipron

World Pharma News

Pfizer Inc. (NYSE: PFE) announced that based on results from the ongoing pharmacokinetic study (NCT06153758), the company has selected its preferred once-daily modified release formulation for danuglipron, an oral glucagon-like peptide-1 (GLP-1) receptor agonist. Pfizer plans to conduct dose optimization studies in the second half of 2024 evaluating multiple doses of the preferred modified release formulation to inform the registration enabling studies.

99
article thumbnail

How the pandemic exposed faulty links in the supply chain

pharmaphorum

The pandemic has exposed vulnerabilities in global supply chains, particularly in the healthcare sector, concerning the production and distribution of essential medical supplies, such as antibiotics and other medications. Learn more about the impact and potential solutions.

98
article thumbnail

Kyverna wins RMAT designation for stiff-person syndrome for cell therapy candidate

Pharmaceutical Technology

Kyverna’s CEO Peter Maag said the biotech is “eager to start generating data” from a Phase II trial.

98
article thumbnail

Pharma Pulse 7/16/24: Universities Don’t Want AI Research to Leave Them Behind, The AI Revolution Comes to Pharmacy & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

96